Invisalign (ALGN) Price to Earnings Ratio

Corporate emblem and logo of Invisalign (ALGN)

Recovering demand for premium aligners and the implementation of digital scanners are creating positive momentum for Align Technology, Inc. (ALGN). The issuer's P/E chart helps assess the premium for business scalability, with 25.00 representing the latest metric reading. Leadership is driven by investments in AI and 3D technologies. Stable margins are achieved by locking clinics into an ecosystem of equipment and consumables.

Align Corp (ALGN) Price to Earnings Ratio: for the period 07/04/2022 - 11/11/2026

Comprehensive metric breakdowns and analytics for Align Technology Inc (ALGN)

- price and consensus price forecast:
Stock Price aligntech.com|ALGN - Price Target Chart
- market capitalization details:
Market Value Align Technology, Inc.|ALGN - Enterprise Value
- book capitalization information:
Net Assets per Share Align Technology|ALGN - Company Net Assets|Market Capitalization to Net Assets aligntech.com|ALGN - Company Total Assets
- debt and solvency information:
Debt to Capital Align Technology, Inc.|ALGN - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Align Corp|ALGN - Company Total Debt|Debt to Net Assets Ratio Align Technology, Inc.|ALGN - Company Long-Term Debt|Company Current Liabilities Align Technology|Immediate Liquidity aligntech.com
- earnings and market multiples details:
ALGN - Net Profit|Net Profit Forecast Align Technology, Inc.|ALGN - P/E Multiple|Market Cap to Projected Earnings Invisalign|ALGN - PEG Multiple|Enterprise Value to EBITDA Ratio Align Technology, Inc.|ALGN - Operating profit EBITDA|Net earnings per share (EPS TTM) Align Technology|ALGN - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months aligntech.com|ALGN - Net earnings per share growth this year|Expected earnings per share trend next year Align Technology, Inc.
General company analysis:aligntech.com - ALGN
Original product of aligntech.com

When screening an issuer for financial stability, an investor assesses the asset's premium through the ratio of market capitalization to annual income. This metric measures the investment payback period by correlating the current share price with net profit per share. For Align Technology, Inc. (ALGN), this calculation reflects the market premium for its technological dominance and the expansion of the iTero ecosystem. By analyzing the P/E ratio based on net income, one can determine the fairness of the business valuation.

Analysis of competing companies

P/E Multiple bostonscientific.com|Price to Earnings Ratio Edwards Lifesciences Corporation (EW)|Price to Earnings Ratio RMD (ResMed Inc)|P/E Multiple PODD (OmniPod)|Business Payback Period Zimmer Biomet (ZBH)|COO: Price to Earnings Ratio|Market Cap to Net Income GMED|TMDX: P/E Multiple|Market Cap to Earnings Alphatec Holdings (ATEC)|AORT (Artivion Inc) - P/E Multiple|Price to Earnings Multiple ENOV (Enovis Inc.)|Price to Earnings Ratio IART (Integra LifeSciences)|ESTA (establishmentlabs.com) - Company Value to Net Income|Price to Earnings Ratio Beta Bionics BBNX|IRMD - Price to Earnings Ratio|Embecta Inc. - P/E Multiple|Market Cap to Earnings Tandem Corp|AXGN: P/E Multiple|Price to Earnings Multiple SIBN|OFIX (Orthofix) - P/E Multiple|Bioventus Inc (BVS) - Business Payback Period|P/E Multiple KIDS|Price to Earnings Ratio Treace Corp TMCI|P/E Multiple SRTA (Strata Critical Medical Inc)|P/E Multiple carlsmed.com CARL|RXST - Price to Earnings Ratio|CLPT: Price to Earnings Ratio|STXS (Stereotaxis Corp) - Price to Earnings Ratio|Neuronetics, Inc - Company Value to Net Income|SGHT (Sight Sciences, Inc.) - P/E Multiple|Market Cap to Earnings orchestrabiomed.com OBIO|Price to Earnings Ratio Anika Therapeutics (ANIK)|InspireMD Inc (NSPR) - Market Cap to Net Income Ratio|Jin Medical - Price to Earnings Ratio|P/E Multiple Vivani Medical Inc VANI|Xtant Medical Inc - P/E Multiple|Business Payback Period n1mtc.com NMTC|modular-medical.com (MODD) - Price to Earnings Ratio|Market Cap to Net Income MYO (Myomo Inc.)|Price to Earnings Ratio Envoy Medical, Inc|Price to Earnings Ratio Vivos Therapeutics Inc (VVOS)|P/E Multiple NVNO|SINT - Market Cap to Earnings|Price to Earnings Ratio Tenon Medical TNON|LFWD: Price to Earnings Multiple|AMIX: Price to Earnings Ratio|INVO Fertility Corp - Market Price to Net Income Ratio|BBLG: P/E Multiple|axonics.com (AXNX) - P/E Multiple|Price to Earnings Ratio BIOLASE|Price to Earnings Ratio DYNT|P/E Multiple FNA|Business Payback Period invobioscience.com